An antibody that has the power to neutralise any influenza strain could be widely administered in the form of a nasal spray ...

Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ...

New appointment strengthens executive leadership commensurate with launch of CARDAMYST™ (etripamil) nasal spray ...

A new Australian study has found that a simple saline nasal spray could help many children breathe and sleep better, ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

Foralumab stabilized disability for 6 months in all 10 people with nonactive SPMS who took part in an expanded access program, a study found.

According to current data, migraines are one of the most common neurological disorders worldwide and in the United States. Worldwide, migraines affect about 40% of the population (3.1 billion people).

Steve Jones was left with an unwanted side effect after undergoing surgery for prostate cancer: erectile dysfunction that ...

SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect ...

Though in early stages of development, this medical innovation that could change the game for high-risk individuals and locations.